Here are eight key updates from spine and orthopedic devicemakers since Feb. 7.
1. Zimmer Biomet on posted fourth-quarter sales of $1.9 billion. Read the full financial report here.
2. The TOPS device, for lumbar facet arthroplasty, is more cost-effective compared to a transforaminal lumbar interbody fusion when addressing degenerative spondylolisthesis and stenosis, according to a study published in The Spine Journal.
3. Medtronic appointed Raman Venkatesh as the company's first chief sustainability officer. The company also shared its financial results for the third quarter of fiscal year 2024.
4. Accelus has added its president and CEO, Kevin McGann, and business leader Bernie Haffey to its board of directors.
5. An appeal board for the European Patent Office has revoked a pain management system patent belonging to California-based medical device company Nevro following a challenge from its competitors Medtronic and Boston Scientific.
6. Smith+Nephew made its Aetos Shoulder System fully commercially available in the U.S.
7. Globus Medical reported $616.5 million in fourth quarter 2023 sales, an increase of 124.6%, and full year sales of $1.6 billion, a 53.3% increase over the prior year.
8. Centinel Spine earned coverage from a large commercial payer in Tennessee for one- and two-level lumbar disc replacement.